Sponsored content brought to you by

SecureCell ogo

Pharmaceuticals have a prominent role in healthcare, and their manufacturing requires innovative tools and scientific and engineering knowledge, and must at the same time comply with strict regulations. Efficient bioprocess development is therefore a challenging endeavor: timely monitoring and control of Critical Process Parameters (CPPs) and Critical Product Attributes (CPAs) are crucial to design, analyze, and control a bioprocess. The goal is not to have to test the quality of the product, but that it is built-in by design. Implementing Process Analytical Technology (PAT) and advanced data analytics is of paramount importance to comply with demands by regulatory bodies, while at the same time efficiently and quickly develop a robust production process.

PAT relies on concepts that are applicable to all manufacturing

  1. Process understanding—The process is understood if all the critical sources of variability are known and managed by the process, and if the product quality attributes are predicted.
  2. Principles and tools—CPPs and CPAs must be identified to establish an effective bioprocess. For example, perturbations and modification are challenging to be detected, collecting representative samples through automatic sampling and at-line analyzers help monitoring and controlling activities. Different classes of tools are included in the PAT system: multivariate tools for design, data acquisition, and analysis; process analyzers; process control tools; and continuous improvement and knowledge management tools.
  3. Strategy for implementation—PAT principles should be applied during the development phase to be able to implement the manufacturing and regulatory system at the same time.

PAT promises higher quality, reduced cost of goods, and faster time to market ensuring different parameters: reduction of variations in CPPs; increased process robustness; fast and predictive up- and downscaling of the process; reduced human intervention, reduced risk of human error, reduced risk of contamination, and timely correction of irregularities; dynamic adjustment to different culture conditions; complexity reduction; increased throughput. Despite those numerous fantastic benefits, the systematic implementation in the industry is lagging behind the ambitious goals set by the PAT initiative in 2004 and delayed by technological limitations that are just being gradually overcome.

Integrated smart bioreactor setups will be key to enable the effective orchestration of various hardware classes and the advanced analytics performed in software. Securecell targets this bottleneck with its PAT tools Numera®, an automated sampling and sample preparation system, and Lucullus®, a process information management system. Some example applications have demonstrated their capabilities to close the prevalent integration gap.

Bioprocess control and data management software—Lucullus®

Process control is a central task in bioprocess development and production. Real-time availability of analytical data is the base for process understanding and production empowerment. A variety of data coming from usually disparate data sources need to be merged in a database to get a complete understanding and better insights into process modeling. Both capabilities are the foundation of collecting and later applying process knowledge in control strategies.

Lucullus® PIMS approach
Practical approach from data to information to knowledge to wisdom or a final application. Illustration of the Lucullus® PIMS approach, which enables a significant speed-up in process development based on extensive data and information management.
    1. Lucullus® PIMS for biochemical engineering at TU Wien—Proffessor Herwigs at TU Wien performs a wide variety of processes from waste to value to biopharmaceuticals using several organisms, such as extremophilic organisms, bacteria, yeasts, and fungi as well as mammalian cells, and numerous reactor systems combined with different equipment. The lab setup requires extreme flexibility and continuous implementation of process chains and control strategies. Lucullus® enables flexible setups of bioreactors systems; intuitive designs and implementation of basic and complex chains; monitoring and control for efficient and robust bioprocesses; centralized, secure data management and a basis for knowledge generation; and speed-up of process development and reduction in time to market.
    2. Lucullus® PIMS for event-based E. coli process controlE. coli are cultured in a pET expression system and auto-induction medium. Typically, the start of induction coincides with a temperature shift. In the first example, the shift is performed based on an in-line optical density (OD) signal; in the second one, Numera® in combination with an HPLC system monitors the consumption of glucose and lactose, and the trigger of the shift is based on substrate consumption and the behavior of the culture. In both processes, Lucullus® controls and automatically initiates the temperature shift. The triggering was efficiently performed by Lucullus® based on real-time data. The combination of Numera® and Lucullus® allows a control strategy based on direct measurement of the analyte of interest and holds a huge potential for optimizing the process in a science-based manner. Process variability can be decreased and productivity stabilized, resulting in a robust process.
devices and interfaces of Lucullus® at TU Wien
Summary of devices and interfaces of Lucullus® at TU Wien.

Automated sampling and analytics—Numera®

Sample-based monitoring has various advantages: direct measurement of specific analytes; usage of highly automated off-line analyzers; reliability through application of reference methods; extensive parallelization; and flexibility and storage of reference samples for later analysis. Numera® allows maintaining those benefits, while still automating those typically manual workflows connected to it. Numera is an accurate (error of 0.4%, can be increased by sample dilutions), highly precise, long-term sterile system that can perform high-frequency, low-volume sampling.

  1. Online HPLC and data integration—A bioreactor containing a CHO culture was equipped with a Numera® connected to an HPLC system, while Lucullus® acted as the overarching solution to control all the parameters and control inputs. Due to the systems’s high precision, the HPLC calibration (0.03–0.01% error) can be performed with Numera® and the dilution factor directly calculated into Lucullus®. Reference analytics can be brought directly to the process, and metabolites (e.g. B-vitamins and IgG) can be monitored for process characterization.
  2. Online analysis with HPLC and Cedex® Bio HT—Amino acids — A bioreactor containing a CHO culture was equipped with a Numera® connected to an HPLC system and a Cedex® Bio HT, while Lucullus® acted as overarching solution to control all the parameters and control inputs. The sample processing required dilutions could be performed by Numera®. A total of 19 amino acids were analyzed online with the HPLC system in 34 minutes, the analytical data were available in Lucullus® 11 minutes later. The same analysis took 19 minutes with the Bio HT system, and the data were available in Lucullus® 11 minutes later. The monitoring of various analytes was performed without significant errors or system failures. The higher measurement frequency and significantly reduced random errors resulted in a larger information content per experiment. (A reliable automated sampling system for online and real-time monitoring of CHO cultures. A. Hofer, P.Kroll, M. Barmettler, C. Herwig)
  3. Online analysis with Cedex® Bio HT—Glucose, lactate, ammonium, and IgG—A bioreactor containing a CHO culture was equipped with a Numera® connected to an HPLC system and a Cedex® Bio HT, while Lucullus® acted as overarching solution to control all the parameters and control inputs. Glucose, lactate, ammonium, and IgG were analyzed. The complete measurement of analytes took 31 minutes in total (19 minutes for the Bio HT analysis). The connection between Numera®, Cedex® Bio HT, bioreactor, and Lucullus® enables the efficient monitoring of substrate, metabolite, and product.


Contact the industry leader in fully automated and integrated bioprocess development to explore your solution at contact@securecell.ch.

Securecell Ltd.
Urdorf (Zurich), Switzerland
© 2020 Securecell AG all rights reserved.
All trademarks are property of Securecell Ltd. and its subsidiaries unless otherwise specified.

Previous articleBioIVT: Ethical Procurement Matters for Quality Human Biospecimens
Next articleInsights from an Industry Forum: Reducing Cost of Goods for Gene Therapy